Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis

This analysis (33 trials, n=260,447 with 15,012 cancer events) found no consistent evidence that antihypertensive medication use had any effect on cancer risk. Evidence for some comparisons was insufficient to entirely rule out excess risk e.g. calcium channel blockers.

Source:

The Lancet Oncology